LNTH — Lantheus Holdings Inc. stock price and chart

Share this page

LNTH

$99.70-0.29%

as of close, Oct 16, 2026

☾ AH $99.70 -0.29%

Lantheus Holdings Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.02%US Stock Market 0.010%Russell 3000 0.010%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

10.020.030.040.050.060.070.080.090.0100.0110.0010.0M20.0M$99.70

2026-10-16

Price$99.70

MA20$100.03

MA50$78.81

Vol7.0M

What would $1,000 invested in LNTH be worth today? →

LNTH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $99.70
YTD price return: +49.81%
YTD total return: +49.81%
Next earnings: Nov 5, 2026
Market cap: 6.5B2016-12 307.2M2026-10 6.5B+2017.9% over the window
Enterprise value: 6.5B
Shares outstanding: 65.3M2016-06 30.4M2026-06 65.3M+114.8% over the window
52W low: $50.16
52W high: $111.86
From 52W high: -10.87%
From 52W low: +98.78%
52W range: 80%

Volume

Rel volume: 1.73×
30D volume: 989.3K
30D $ vol: 99M

Fundamentals

Sales (ttm): 1.6B2016-06 299.8M2026-06 1.6B+419.2% over the window
Sales/share: $23.842016-06 $9.862026-06 $23.84+141.7% over the window
EPS (ttm): $4.122016-06 $0.892026-06 $4.12+362.4% over the window
FCF (ttm): 390.1M2015-12 8.6M2025-12 390.1M+4430.7% over the window
FCF/share: $5.982015-12 $0.272025-12 $6.04+2107.5% over the window
Book value/share: $20.102016-06 -$5.472026-06 $20.10-467.1% over the window
Net margin: 17.69%2016-06 9.0%2026-06 17.7%+96.6% over the window
ROE: 20.99%2017-12 529.8%2026-06 21.0%-96.0% over the window
ROA: 11.40%2016-06 10.4%2026-06 11.4%+9.6% over the window
Debt / equity: 0.43×2017-12 11.392026-06 0.43-96.2% over the window
Current ratio: 3.062016-06 3.322026-06 3.06-7.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +2.35%2025-06-30 → 2026-06-301.5B → 1.6B (+2.3% total)+11.42%2023-06-30 → 2026-06-301.1B → 1.6B (+38.3% total)+32.84%2021-06-30 → 2026-06-30376.3M → 1.6B (+313.6% total)+17.91%2016-06-30 → 2026-06-30299.8M → 1.6B (+419.2% total)
Net income: +1.59%2025-06-30 → 2026-06-30271M → 275.3M (+1.6% total)+102.03%2023-06-30 → 2026-06-3033.4M → 275.3M (+725.0% total)n/a+26.15%2016-06-30 → 2026-06-3027M → 275.3M (+920.6% total)
FCF: -15.90%2024-12-31 → 2025-12-31463.8M → 390.1M (-15.9% total)+161.59%2022-12-31 → 2025-12-3121.8M → 390.1M (+1691.2% total)+88.51%2020-12-31 → 2025-12-3116.4M → 390.1M (+2279.5% total)+46.42%2015-12-31 → 2025-12-318.6M → 390.1M (+4430.7% total)
Shares: -4.01%2025-06-30 → 2026-06-3068M → 65.3M (-4.0% total)-1.56%2023-06-30 → 2026-06-3068.4M → 65.3M (-4.6% total)-0.70%2021-06-30 → 2026-06-3067.6M → 65.3M (-3.4% total)+7.95%2016-06-30 → 2026-06-3030.4M → 65.3M (+114.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +9.12%2025-06-30 → 2026-06-30$3.77 → $4.12 (+9.1% total)+105.22%2023-06-30 → 2026-06-30$0.48 → $4.12 (+764.8% total)n/a+16.55%2016-06-30 → 2026-06-30$0.89 → $4.12 (+362.4% total)
Sales/share: +6.62%2025-06-30 → 2026-06-30$22.36 → $23.84 (+6.6% total)+13.19%2023-06-30 → 2026-06-30$16.44 → $23.84 (+45.0% total)+33.78%2021-06-30 → 2026-06-30$5.57 → $23.84 (+328.4% total)+9.23%2016-06-30 → 2026-06-30$9.86 → $23.84 (+141.7% total)
FCF/share: -10.86%2024-12-31 → 2025-12-31$6.77 → $6.04 (-10.8% total)+165.49%2022-12-31 → 2025-12-31$0.32 → $6.04 (+1772.5% total)+89.87%2020-12-31 → 2025-12-31$0.24 → $6.04 (+2366.5% total)+36.26%2015-12-31 → 2025-12-31$0.27 → $6.04 (+2107.5% total)
Book value/share: +17.13%2025-06-30 → 2026-06-30$17.16 → $20.10 (+17.1% total)+35.50%2023-06-30 → 2026-06-30$8.08 → $20.10 (+148.8% total)+21.74%2021-06-30 → 2026-06-30$7.52 → $20.10 (+167.4% total)n/a
Price: +76.97%2025-10-16 → 2026-10-16$56.36 → $99.70 (+76.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+12.76%2023-10-16 → 2026-10-16$69.54 → $99.70 (+43.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+33.77%2021-10-15 → 2026-10-16$23.26 → $99.70 (+328.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+29.17%2016-10-14 → 2026-10-16$7.70 → $99.70 (+1194.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +76.97%2025-10-16 → 2026-10-16$56.36 → $99.70 (+76.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.76%2023-10-16 → 2026-10-16$69.54 → $99.70 (+43.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+33.77%2021-10-15 → 2026-10-16$23.26 → $99.70 (+328.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+29.17%2016-10-14 → 2026-10-16$7.70 → $99.70 (+1194.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 24.2×2016-12 11.902026-10 23.64+98.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 21.5×2016-12 5.412026-10 21.52+298.1% over the window
Fwd P/E: 15.7×
P/S (ttm)Market cap ÷ TTM revenue.: 4.2×2016-12 1.032026-10 4.18+306.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.0×2016-12 -2.542026-10 4.96-295.6% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 16.7×2016-12 7.722026-10 16.68+115.9% over the window
EV/EBITDA (fy): 16.7×
EV/Sales (ttm): 4.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.00%2016-09 12.9%2025-12 9.1%-29.9% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 65.3M ÷ 68.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.01%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($5.6B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.01%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($200M) ÷ today's market cap ($6.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 3.07%2016-09 -13.5%2026-06 2.8%-120.4% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $200M + TTM dividends $0) ÷ today's market cap ($6.5B). Same caveat as the cash buyback yield.: 3.07%2016-09 -13.5%2026-06 2.8%-120.4% over the window

Vs own 10Y history

P/E: 62nd
P/OI: 72nd
P/S: 68th
P/B: 37th
P/FCF: 41st

Bar = where today’s multiple sits in LNTH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-0.29%

-0.45%

-0.84%

-5.14%

YTD

+49.81%

+76.90%

+328.63%

Financial statements

Open full LNTH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

LNTH — Lantheus Holdings Inc. price, chart and key statistics